‘Clinical Trial’ etiketi için içerik arşivleri
Yikes! It’s been a while, hasn’t it?
Leigh Carlisle, a 27-year-old cancer sufferer who is pioneering new treatment for a deadly asbestos-related form of the illness, mesothelioma, is beginning to beat the disease.
Mesothelioma is a cancer known to affect the tissue that surrounds our organs and fills the spaces in between them. It’s primarily caused by exposure to asbestos, and is more common in adults over the age of 65. Even so, it is possible for younger people to end up with a terminal mesothelioma cancer diagnosis. [...]
Typically the most important variable determining the prognosis and life expectancy of a mesothelioma patient is the stage of the cancer when it is diagnosed. Unfortunately, mesothelioma is more difficult to “stage” than other cancers. This is true for a couple of reasons:
(ACEL) announced that it has entered into a purchase and supply agreement with Scientific Protein Laboratories LLC or SPL for the commercial production of Onconase or ranpirnase.
Although mesothelioma has no cure, clinical trials are being conducted to test new drugs and procedures to fight against the disease. Phase one trials typically enroll a small amount of people to test how new drugs and procedures should be administered. Phase two trials focus on whether new drugs and procedures are effective. Phase three [...]